Use of mHealth to Increase Physical Activity for Patients Recently Hospitalized With Acute Heart Failure
mRehab
1 other identifier
interventional
116
1 country
1
Brief Summary
The aim of this trial is to determine if a mobile application that promotes physical exercise in the follow-up of patients recently hospitalized with acute heart failure can improve exercise capacity after 6 months and physical activity levels compared to the standard follow-up. A randomized clinical trial will be conducted with 100 consecutive patients aged +18 years, hospitalized for acute decompensated heart failure in a tertiary referral hospital who own a mobile phone compatible with MyPlan and access to Wi-Fi or mobile data. At discharge, patients will be randomly assigned in two groups; the intervention group will be followed with a smartphone application to promote physical activity, whereas the control group will take responsibility in their adherence to exercise recommendations. Main study variables will be functional capacity after 6 months, which will be evaluated using the six minute walking test, and physical activity levels, using the International Physical Activity Questionnaire (IPAQ). The study will be analyzed using the intention-to-treat principle. The project has been authorized by the local committee for ethics in clinical research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Apr 2021
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 8, 2021
CompletedFirst Posted
Study publicly available on registry
April 19, 2021
CompletedStudy Start
First participant enrolled
April 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2024
CompletedMay 31, 2025
May 1, 2025
3.1 years
April 8, 2021
May 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in 6-minute walking distance (6MWD)
6 months
Secondary Outcomes (1)
Participant reported physical activity levels, using the International Physical Activity Questionnaire (IPAQ)
6 months
Other Outcomes (10)
Muscle strength - measured using the Medical Research Council (MRC) Sum Score
6 months
Upper limb strenght - measured by hand-held dynamometry
6 months
Rectus femoris muscle diameter
6 months
- +7 more other outcomes
Study Arms (2)
Mobile Health Arm
EXPERIMENTALControl Arm
NO INTERVENTIONThe Control Arm will receive standard of care including tailored prescription of physical activity
Interventions
The Mobile Health Arm will receive standard of care including tailored prescription of physical activity as well as the mobile health intervention, which will have the following features: * Goal setting for frequency and duration of exercise sessions * Graphic feedback and reinforcement with educational and motivational messages tailored to user's exercise adherence. * Problem-solving support * Library with educational tips and information regarding physical exercise.
Eligibility Criteria
You may qualify if:
- Aged +18 years
- Hospitalized for acute decompensated heart failure in a tertiary referral hospital
- Owning a mobile phone compatible with MyPlan and access to Wi-Fi or mobile data (either the patient or the caregiver)
You may not qualify if:
- NYHA IV patients
- Currently listed for heart transplant
- Left ventricular assist device recipient
- Ventricular arrhythmia within prior 6 months
- Uncontrolled arterial hypertension or resting heart rate \>100 bpm
- Acute myocarditis or pericarditis
- Severe aortic stenosis
- Hypertrophic obstructive cardiomyopathy
- Advanced AV block
- Muscle-skeletal or neurologic disease preventing to perform study procedures
- ACS within prior month
- Severe lung disease
- Moderate or severe cognitive impairment
- Unable/unwilling to consent
- Projected life expectancy \<6 months
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sonia Mirabet, Ph. D.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2021
First Posted
April 19, 2021
Study Start
April 22, 2021
Primary Completion
June 10, 2024
Study Completion
June 10, 2024
Last Updated
May 31, 2025
Record last verified: 2025-05